Literature DB >> 18406881

Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography.

Michael P Macmanus, Rodney J Hicks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18406881     DOI： 10.1016/j.ijrobp.2008.01.019

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

1.  Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects.

Authors:  E J Somer; L C Pike; P K Marsden
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

2.  Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague.

Authors:  C Doll; V Duncker-Rohr; G Rücker; M Mix; M MacManus; D De Ruysscher; W Vogel; J G Eriksen; W Oyen; A-L Grosu; W Weber; U Nestle
Journal:  Strahlenther Onkol       Date:  2014-03-11       Impact factor: 3.621

3.  Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.

Authors:  G G Hanna; J R Van Sörnsen De Koste; K J Carson; J M O'Sullivan; A R Hounsell; S Senan
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

Review 4.  Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research.

Authors:  Alesia Ivashkevich; Christophe E Redon; Asako J Nakamura; Roger F Martin; Olga A Martin
Journal:  Cancer Lett       Date:  2011-12-21       Impact factor: 8.679

5.  Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning.

Authors:  Antoni Vila; Alberto Sánchez-Reyes; Carles Conill; Juan Domingo Gispert; Carlos Trampal; Carmen Láinez; Jordi Vayreda; Agustí Pedro
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

6.  Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.

Authors:  Paolo Farace; Daniela D'Ambrosio; Flavia Merigo; Mirco Galiè; Cristina Nanni; Antonello Spinelli; Stefano Fanti; Anna Degrassi; Andrea Sbarbati; Domenico Rubello; Pasquina Marzola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-18       Impact factor: 9.236

7.  IMRT: preliminary results in a series of advanced head-and-neck cancer patients.

Authors:  Antonio Vila Capel; Jorge Vilar Palop; Agustín Pedro Olivé; Alberto Sanchez-Reyes Fernandez; Jordi Vayreda Ribera; Joan Carles Julià Sanahuja; Joaquim Pérez de Olaguer Agustín; Nuria Artola Codina; Luis Miguel Moya Cascant; Esther Rubio Calatayud; Gemma Carrera Domenech
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

8.  Optimal definition of biological tumor volume using positron emission tomography in an animal model.

Authors:  Ingrid Wu; Hao Wang; David Huso; Richard L Wahl
Journal:  EJNMMI Res       Date:  2015-10-21       Impact factor: 3.138

9.  Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.

Authors:  Yanluan Guo; Jianbin Li; Peng Zhang; Qian Shao; Min Xu; Yankang Li
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

10.  Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume.

Authors:  Andrew Scarsbrook; Gillian Ward; Patrick Murray; Rebecca Goody; Karen Marshall; Garry McDermott; Robin Prestwich; Ganesh Radhakrishna
Journal:  BMC Cancer       Date:  2017-10-04       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.